Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harrow (HROW) Gains from Sales and Divestitures (2016 - 2025)

Harrow (HROW) has 11 years of Gains from Sales and Divestitures data on record, last reported at $98444.0 in Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures fell 69.99% year-over-year to $98444.0; the TTM value through Dec 2025 reached $98444.0, down 69.99%, while the annual FY2025 figure was $98444.0, 69.99% down from the prior year.
  • Gains from Sales and Divestitures reached $98444.0 in Q4 2025 per HROW's latest filing, up from $91861.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $1.6 million in Q2 2025 and bottomed at $4173.0 in Q1 2025.
  • Average Gains from Sales and Divestitures over 5 years is $394289.6, with a median of $189965.5 recorded in 2022.
  • Peak YoY movement for Gains from Sales and Divestitures: skyrocketed 6297.37% in 2021, then crashed 98.53% in 2025.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $1.3 million in 2021, then crashed by 81.4% to $237098.0 in 2022, then decreased by 25.92% to $175643.0 in 2023, then soared by 86.74% to $327998.0 in 2024, then tumbled by 69.99% to $98444.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $98444.0 in Q4 2025, $91861.0 in Q3 2025, and $1.6 million in Q2 2025.